US pharmacy pricing
Praluent Cost Without Insurance — US Pharmacy Price Guide
Lowest price found · US pharmacies
$527.39/fill
for Praluent, across the pharmacies in our data
US pharmacy prices — 1ml of 75mg/ml
| Pharmacy | Discount-card price | Regular cash price | Average retail |
|---|---|---|---|
| $527.39Lowest | $530.39 | $272.75 | |
| $527.39Lowest | $530.39 | $272.75 | |
| $554.93 | $557.93 | $272.75 | |
| $559.40 | $562.40 | $270.53 | |
| $565.65 | $568.65 | $272.75 | |
| $569.29 | $572.29 | $285.03 |
"Discount-card price" reflects a standard prescription discount card, not insurance. Prices change often — confirm at the pharmacy before filling.
Interchangeable forms
Per RxNorm (U.S. National Library of Medicine), these share the same active ingredient and strength as Praluent.
Frequently asked questions
Is Praluent (Praluent) expensive if I don't have insurance?
At the US pharmacies in our data, the lowest listed discount-card price for Praluent is around $527.39. Prices vary by pharmacy, dosage, and pack size, so use the table above to compare specific options near you.
Is a generic version of Praluent available?
Generic and brand-name pricing for Praluent is broken out in the tables above where both exist in our data. Generic versions are typically the lower-cost option, but availability depends on the specific formulation and dosage.
Is a generic version of Praluent available?
Praluent is a brand-name medication manufactured by Regeneron Pharmaceuticals. Its active ingredient is alirocumab. As of now, no generic (bioequivalent) version of Praluent has been approved for sale in the United States.
What is Praluent and what is it used for?
Praluent is an injectable prescription drug containing alirocumab, a PCSK9 inhibitor monoclonal antibody. It works by helping the liver remove LDL cholesterol from the bloodstream. It is FDA-approved to lower the risk of heart attack, stroke, and certain types of chest pain in adults with cardiovascular disease. It is also used, alongside diet and other cholesterol medications, to treat primary hyperlipidemia (including hereditary high cholesterol) and, in combination with other drugs, to treat homozygous familial hypercholesterolemia. Praluent is not approved for use in children under 18. It should not be used by anyone allergic to alirocumab. Before starting treatment, inform your doctor of all your medical conditions, other medications (including supplements), and if you are pregnant or planning to become pregnant, as the drug's effects on a fetus are not fully understood.
What are the available strengths for Praluent?
Praluent is administered as a subcutaneous injection (under the skin). It is supplied as a solution in pre-filled pens, available in two concentrations: 75 mg per milliliter and 150 mg per milliliter.